| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |